Clinical Trial Update: A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 master protocol study sponsored by Eli Lilly evaluating multiple drugs in adults with ulcerative colitis or Crohn's disease; currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colitis, Ulcerative, Crohn Disease | Phase 2 | Status: NOT_YET_RECRUITING